Clinical Trial Update: Enhancement by Poly-ICLC During HIV-1 Infection [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Poly-ICLC as an enhancer during HIV-1 infection completed, with results posted in March 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Poly-ICLC (poly-ICLC)

Snippet

Sponsor: Nina Bhardwaj | Conditions: HIV-1 Infected Adults With Chronic HIV-1 Infection | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-03-13